Risk of Sudden Death in Brugada (RB Score) Calculator

Clinical calculation support · Verify results before clinical use

Clinical inputs

Select the findings documented for the patient. All four items are required to calculate the legacy point tally.

— Points
Spontaneous type 1 Brugada ECG

Spontaneous type 1 Brugada ECG

Spontaneous type 1 pattern on ECG; distinguish this from a pattern seen only after sodium-channel blocker challenge.

+1 point
History of syncope

History of syncope

Record the clinical history. Whether syncope is likely arrhythmic requires clinical assessment.

+2 points
Family history of sudden cardiac death

Family history of sudden cardiac death

Consider the circumstances, age, and relationship of the deceased relative during specialist assessment.

+1 point
Inducible VT/VF on electrophysiology study

Inducible VT/VF on electrophysiology study

Enter the result only if an electrophysiology study has been performed.

+2 points
Reset

About this point tally

The original source code assigns 1 point for spontaneous type 1 ECG, 2 points for history of syncope, 1 point for family history of sudden cardiac death, and 2 points for inducible VT/VF on electrophysiology study. The arithmetic maximum is therefore 6 points, not 5 as stated in the original explanatory text.

These weights and the original low/intermediate/high categories are retained here only as a transparent legacy calculation, not as a clinically validated prediction model. The referenced PRELUDE registry did not establish this four-item weighted score or these cutoffs.

Weights used by the original file

VariableOriginal weight
Spontaneous type 1 Brugada ECG1
History of syncope2
Family history of sudden cardiac death1
Inducible VT/VF on electrophysiology study2
Maximum possible tally6

Important evidence context

In the prospective PRELUDE registry, spontaneous type 1 ECG and history of syncope were associated with arrhythmic events, while inducibility of VT/VF during programmed electrical stimulation was not predictive of events during follow-up. These findings do not validate the legacy point weights or its risk categories.

Scientific references

Priori SG, Gasparini M, Napolitano C, et al. Risk Stratification in Brugada Syndrome: Results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) Registry. Journal of the American College of Cardiology. 2012;59(1):37–45. doi:10.1016/j.jacc.2011.08.064 · PubMed PMID: 22192666
Gaita F, et al. A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK). JACC: Clinical Electrophysiology. 2021;7(2). doi:10.1016/j.jacep.2020.08.032

The PRELUDE registry and BRUGADA-RISK model are cited to check the original clinical explanation and distinguish it from published risk approaches. Neither validates the four-item weights and legacy cutoffs implemented in the original file.

Clinical disclaimer: This tool is educational and does not replace a complete evaluation by a clinician experienced in inherited arrhythmia syndromes. A point tally must not be interpreted as an absolute risk percentage or used as the sole basis for an implantable cardioverter-defibrillator decision. Consider symptoms and their likely mechanism, ECG phenotype, family history details, other ECG markers, electrophysiology findings when appropriate, and current specialist guidance.